Sleep Breath 2002; 06(1): 003-010
DOI: 10.1055/s-2002-23150
ORIGINAL ARTICLE

Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Long-Term Effects of Treatment with Nasal Continuous Positive Airway Pressure on Lung Function in Patients with Overlap Syndrome

Javier de Miguel1 , Jorge Cabello2 , José M.F.  Sánchez-Alarcos1 , Rudolfo Álvarez-Sala3 , Domingo Espinós2 , José L. Álvarez-Sala1
  • 1Department of Pulmonology, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Madrid, Spain
  • 2Department of Internal Medicine, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Madrid, Spain
  • 3Department of Pulmonology, Hospital Universitario ``La Paz,'' Madrid, Spain
Further Information

Publication History

Publication Date:
26 March 2002 (online)

ABSTRACT

We assessed the effects of chronic nasal continuous positive airway pressure (CPAP) therapy on lung function in a series of unselected patients with overlap syndrome, and we determined whether there were differences in the response induced by CPAP between hypercapnic (PaCO2 ≥ 45 mm Hg) and eucapnic patients with overlap syndrome. The study population included 55 unselected patients (48 men, mean age of 58.5 ± 10.5 years) with a concurrent diagnosis of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea-hypopnea syndrome (OSAHS) who had been referred to the Department of Pulmonology of our hospital over 2 consecutive years and in whom work-up studies resulted in the prescription of nasal CPAP therapy. An apnea-hypopnea index (AHI) greater than or equal to 10 in the cardiorespiratory polygraphy was required for the diagnosis of OSAHS. A forced expiratory volume in one second (FEV1) less than 80% and FEV1-forced vital capacity (FVC) ratio less than 70% of the reference values were required for the diagnosis of COPD. Control lung function studies and arterial blood gas measurements were performed at 6 and 18 months of CPAP therapy. These patients with overlap syndrome accounted for 28.5% of all patients with OSAHS treated with CPAP during the study period. The mean AHI was 37.3 ± 26.1 and the mean CPAP level 7.3 ± 1.3 cm H2O. Thirty-three patients were hypercapnic (PaCO2 ≥ 45 mm Hg) and 22 eucapnic. The hypercapnic group had higher AHI value (44.3 ± 26.9) than the eucapnic group (28.6 ± 21.9) (P < 0.05). After 6 months of CPAP therapy, there were statistically significant increases in PaO2, FEV1, and FVC, accompanied by significant decreases in PaCO2, serum bicarbonate levels, and alveolar-arterial oxygen difference. Response of overlap syndrome patients to CPAP therapy was superior in the hypercapnic group, particularly in relation to improvement of arterial blood gases. However, statistically significant differences in all parameters for the comparison between 6 and 18 months were not recorded.

REFERENCES

  • 1 Flenley D C. Sleep in chronic obstructive lung disease.  Clin Chest Med . 1985;  6 51-61
  • 2 Catterall J R, Douglas N J, Calverley P MA. Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome.  Am Rev Respir Dis . 1983;  128 24-29
  • 3 Connaughton J J, Catterall J R, Elton R A, Stradling J R, Douglas N J. Do sleep studies contribute to the management of patients with severe chronic obstructive pulmonary disease?.  Am Rev Respir Dis . 1988;  138 341-344
  • 4 Calderón E, Carmona C, Arenas M, Fuentes M A, Sánchez A, Capote F. Estudio comparativo de pacientes con enfermedad pulmonar obstructiva crónica con y sin síndrome de apneas obstructivas durante el sueño.  Arch Bronconeumol . 1999;  35 539-543
  • 5 Chaouat A, Weitzenblum E, Krieger J. Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP.  Eur Respir J . 1999;  13 1091-1096
  • 6 Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome.  Am J Respir Crit Care Med . 1995;  151 82-86
  • 7 Mayos M, Hernández L, Farré A, Sanchis J. Efecto de la oxigenoterapia nocturna en el paciente con síndrome de apnea-hipopnea del sueño y limitación crónica al flujo aéreo.  Arch Bronconeumol . 2001;  37 65-68
  • 8 Sforza E, Krieger J, Weitzenblum E, Apprill M, Lampert E, Ratamaharo J. Long-term effects of treatment with nasal continuous positive airway pressure on daytime lung function and pulmonary hemodynamics in patients with obstructive sleep apnea.  Am Rev Respir Dis . 1990;  141 866-870
  • 9 Rapoport D M, Sorkin B, Garay S M, Goldring R M. Reversal of the ``Pickwickian syndrome'' by long-term use of nocturnal nasal-airway pressure.  N Engl J Med . 1982;  307 931-933
  • 10 Frith R W, Cant B R. Severe obstructive sleep apnoea treated with long-term nasal continuous positive airway pressure.  Thorax . 1985;  40 45-50
  • 11 Young I H, Mihalyka M, Costas L, Sullivan C E. Long-term lung function changes in patients with obstructive sleep apnoea during treatment with nasal continuous positive airway pressure [abstract].  Thorax . 1987;  42 722
  • 12 Leech J A, Önal E, Lopata M. Nasal CPAP continues to improve sleep-disordered breathing and daytime oxygenation over long-term follow-up of occlusive sleep apnea syndrome.  Chest . 1992;  102 1651-1655
  • 13 Vázquez R, Cano S, Capote F, Sánchez M A, Carmona C, Castillo J. Efectos de la presión positiva continua nasal (CPAPn) sobre la función pulmonar en pacientes con síndrome de apnea obstructiva del sueño (SAOS).  Arch Bronconeumol . 1995;  31 18-22
  • 14 Mansfield D, Naughton M T. Effects of continuous positive airway pressure on lung function in patients with chronic obstructive pulmonary disease and sleep disordered breathing.  Respirology . 1999;  4 365-370
  • 15 Standards of Practice Committee of the American Sleep Disorders Association. Practice parameters for the use of portable recording in the assessment of obstructive sleep apnea.  Sleep . 1994;  17 372-377
  • 16 Commission des Communautés Européennes. Aide-mémoire pour la pratique de l'examen de la fonction ventilatoire par la spirographie. Collection d'Hygiènie et de Médecine du Travail 2nd ed. Luxembourg: European Economic Community; 1971
  • 17 Chan C S, Woolcock A J, Sullivan C E. Nocturnal asthma: role of snoring and obstructive sleep apnea.  Am Rev Respir Dis . 1988;  137 1502-1504
  • 18 Nadel J A, Widdicombe J G. Reflex effects of upper airway irritation on total lung resistance and blood pressure.  J Appl Physiol . 1962;  17 861-865
  • 19 Ryan C F, Lowe A A, Li D, Fleetham J A. Magnetic resonance imaging of the upper airway obstructive sleep apnea before and after chronic nasal continuous positive airway pressure therapy.  Am Rev Respir Dis . 1991;  144 939-944
  • 20 Mezzanotte W S, Tangel D J, Fox A M, Ballard R D, White D P. Nocturnal nasal continuous positive airway pressure in patients with chronic obstructive pulmonary disease. Influence on waking respiratory muscle function.  Chest . 1994;  106 1100-1108
  • 21 Martin J G, Shore S, Engel L A. Effect of continuous positive airway pressure on respiratory mechanics and pattern of breathing in induced asthma.  Am Rev Respir Dis . 1982;  126 812-817
  • 22 Petrof B J, Calderini E, Gottfried S B. Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD.  J Appl Physiol . 1990;  69 179-188
  • 23 Petrof B J, Kimoff R J, Levy R D, Cosio M G, Gottfried S B. Nasal continuous positive airway pressure facilitates respiratory muscle function during sleep in severe chronic obstructive pulmonary disease.  Am Rev Respir Dis . 1991;  143 928-935
  • 24 Petrof B J, Legaré M, Goldberg P, Milic-Emili J, Gottfried S B. Continuous positive airway pressure reduces work of breathing and dyspnea during weaning from mechanical ventilation in severe chronic obstructive pulmonary disease.  Am Rev Respir Dis . 1990;  141 281-289
  • 25 Krachman S L, Quaranta A J, Berger T J, Criner G J. Effects of noninvasive positive pressure ventilation on gas exchange and sleep in COPD patients.  Chest . 1997;  112 623-628
  • 26 Rossi A, Santos C, Roca J, Torres A, Félez M A, Rodríguez-Roisin R. Effects of PEEP on VA/Q mismatching in ventilated patients with chronic airflow obstruction.  Am J Respir Crit Care Med . 1994;  149 1077-1084
  • 27 Han F, Chen E, Wei H. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome.  Chest . 2001;  119 1814-1819